Jh. Alexander et al., Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation, J AM MED A, 283(3), 2000, pp. 347-353
Citations number
46
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Context Controversy surrounds the diagnostic and prognostic importance of s
lightly elevated cardiac markers in patients with acute coronary syndromes
without ST-segment elevation.
Objectives To investigate the relationship between peak creatine kinase (CK
)-MB level and outcome and to determine whether a threshold CK-MB level exi
sts below which risk is not increased.
Design and Setting Retrospective observational analysis of data from the in
ternational Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Sup
pression Using Integrilin Therapy (PURSUIT) trial, conducted from November
1995 to January 1997,
Patients A total of 8250 patients with acute coronary sydromes without ST-s
egment elevation who had at least 1 CK-MB sample collected during their ind
ex hospitalization.
Main Outcome Measure Mortality at 30 days and 6 months, was assessed by cat
egory of index-hospitalization peak CK-MB level (0-1, >1-2, >2-3, >3-5, >5-
10, or >10 times the upper limit of normal). Multivariable logistic regress
ion was used to determine the independent prognostic significance of peak C
K-MB level after adjustment for baseline predictors of 30-day and 6-month m
ortality.
Results Mortality at 30 days and 6 months increased from 1.8% and 4.0%, res
pectively, in patients with normal peak CK-MB levels, to 3.3% and 6.2% at p
eak CK-MB levels 1 to 2 times normal, to 5.1% and 7.5% at peak CK-MB levels
3 to 5 times normal, and to 8.3% and 11.0% at peak CK-MB levels greater th
an 10 times normal. Log-transformed peak CK-MB levels were predictive of ad
justed 30-day and 6-month mortality (P<.001 for both).
Conclusions Our data show that elevation of CK-MB level is strongly related
to mortality in patients with acute coronary syndromes without ST-segment
elevation, and that the increased risk begins with CK-MB levels just above
normal. in the appropriate clinical context, even minor CK-MB elevations sh
ould be considered indicative of myocardial infarction.